Illumina (United States)

Recent papers from Illumina (United States)

1. Non-invasive genomic sampling uncovers novel connectivities and origins of confiscated gorillasGenome biology · 2026
2. Clonal haematopoiesis subtypes confer dose-dependent risk of serious bacterial infectionNature Communications · 2026
3. Rapid Whole Genome Sequencing Enhances Pediatric Cancer DiagnosisNature Communications · 2026
4. Financing and Health System Capacity for Precision Medicine in Asia: A Six Country Landscape AnalysisHealth Affairs Scholar · 2026
5. Comparison of tsunami evacuation map designs, warnings, and risk perceptions in Aotearoa New ZealandInternational Journal of Disaster Risk Reduction · 2026
6. Diagnostic performance and clinical utility of targeted next-generation sequencing for diagnosing lower respiratory tract infections in intensive care unit patientsScientific Reports · 2026
7. Clinical harm from failure to deploy personalized medicine for patients with metastatic non–small cell lung cancerJournal of Managed Care & Specialty Pharmacy · 2026
8. Coordinated circulating and tissue-based T cell responses precede xenograft rejection 2308959The Journal of Immunology · 2026
9. RiboZAP: a species-agnostic pipeline for rRNA depletion probe design in metatranscriptomicsBMC Bioinformatics · 2026
10. Physicochemical and Phytochemical Standardization of Ma‘jūn-i-KundurHippocratic Journal of Unani Medicine · 2026
11. Early Mucosal Type II Interferon Limits SARS-CoV-2 Replication in Humans2026
12. Semaglutide attenuates a proteomics‐based dementia risk signature in older adults with overweight or obesity and cardiovascular disease without diabetes: A post hoc analysis of the SELECT phase 3 trialAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2026
13. Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene PanelsOncology and Therapy · 2026
14. Response to commentary on Tanga et al. (2025): Experimental design and interpretation of phosphorus concentration responses under Controlled DrainageAgricultural Water Management · 2026
15. Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3DNature Communications · 2026
16. Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyBlood · 2026
17. A Widely Used CRP Aptamer Does Not Bind CRP, Revealing a General Route to Surface-Driven Pseudoaffinity in BiosensorsBiosensors and Bioelectronics · 2026
18. Correction: Betschart et al. Comprehensive Analysis of the Genetic Variation in the LPA Gene from Short-Read Sequencing. BioMed 2024, 4, 156–170BioMed · 2026
19. Comprehensive genomic profiling of matched ctDNA and tissue from patients with four common cancers enrolled to the NCI-MATCH trial.Journal of Clinical Oncology · 2026
20. Quantum mechanics-based multi-tensor AI/ML as predictor of patients' overall survival, gene targets, and drug responses from their glioblastoma tumors' whole genomes.Journal of Clinical Oncology · 2026